Código QR (código de barras bidimensional)

Spironolactone use is associated with improved outcomes in heart failure with mid‐range ejection fraction

Abstract Aims Spironolactone has been shown to improve outcomes in patients with heart failure (HF) with reduced ejection fraction (EF). We investigated whether the discharge use of spironolactone could be associated with better long‐term outcomes among patients with HF with mid‐range EF (HFmrEF). M...

תיאור מלא

שמור ב:
Principais autores: Nobuyuki Enzan, Shouji Matsushima, Tomomi Ide, Hidetaka Kaku, Taiki Higo, Miyuki Tsuchihashi‐Makaya, Hiroyuki Tsutsui
פורמט: Artigo
שפה:Inglês
יצא לאור: Oxford University Press 2020-02-01
סדרה:ESC Heart Failure
נושאים:
Spironolactone
Heart failure with mid‐range ejection fraction
Outcomes
Rehospitalization
גישה מקוונת:https://doi.org/10.1002/ehf2.12571
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים